Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.690
-0.070 (-3.98%)
Jul 29, 2026, 2:01 PM EDT - Market open
BDTX Market Cap
BDTX has a market cap or net worth of $96.84 million as of July 29, 2026. Its market cap has decreased by -41.88% in one year.
Market Cap
96.84M
Enterprise Value
475.12K
1-Year Change
-41.88%
Ranking
Category
Stock Price
$1.69
ChartMarket Cap Chart
Since January 30, 2020, BDTX's market cap has decreased from $1.36B to $96.84M, a decrease of -92.85%. That is a compound annual growth rate of -33.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 96.84M | -30.05% |
| Dec 31, 2025 | 138.45M | 14.33% |
| Dec 31, 2024 | 121.09M | -16.54% |
| Dec 29, 2023 | 145.09M | 121.66% |
| Dec 30, 2022 | 65.46M | -66.10% |
| Dec 31, 2021 | 193.10M | -83.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 105.10M |
| ImmuCell | 100.69M |
| Rani Therapeutics Holdings | 100.36M |
| Coya Therapeutics | 100.04M |
| Gossamer Bio | 97.48M |
| Pelthos Therapeutics | 95.89M |
| Aldeyra Therapeutics | 95.61M |
| Oncolytics Biotech | 95.50M |